Analysis of Three Mutations in Italian Strains of Sars-Cov Implications for Pathogenesis
| dc.contributor.author | Benvenuto, Domenico | |
| dc.contributor.author | Benedetti, Francesca | |
| dc.contributor.author | Demir, Ayse Banu | |
| dc.contributor.author | Ciccozzi, Massimo | |
| dc.contributor.author | Zella, Davide | |
| dc.date.accessioned | 2023-06-16T14:31:37Z | |
| dc.date.available | 2023-06-16T14:31:37Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped virus initially detected in Wuhan in December 2019, responsible for coronavirus disease 2019 (COVID-19), a respiratory syndrome currently affecting >220 countries around the world, with >80 million cases registered and >1.8 million deaths. Objective: As several vaccines are still being developed and 2 have been approved, it is particularly important to perform evolutionary surveillance to identify mutations potentially affecting vaccine efficacy. Methods: DynaMut server has been used to evaluate the impact of the mutation found on SARS-CoV-2 isolates available on GISAID. Results: In this article, we analyze whole genomes sequenced from Italian patients, and we report the characterization of 3 mutations, one of which presents in the spike protein. Conclusion: The mutations analyzed in this article can be useful to evaluate the evolution of SARS-CoV-2. | en_US |
| dc.identifier.doi | 10.1159/000515342 | |
| dc.identifier.issn | 0009-3157 | |
| dc.identifier.issn | 1421-9794 | |
| dc.identifier.scopus | 2-s2.0-85103314146 | |
| dc.identifier.uri | https://doi.org/10.1159/000515342 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/2158 | |
| dc.language.iso | en | en_US |
| dc.publisher | Karger | en_US |
| dc.relation.ispartof | Chemotherapy | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Bioinformatic | en_US |
| dc.subject | Coronavirus disease 2019 | en_US |
| dc.subject | Evolutionary analysis | en_US |
| dc.subject | Protein modeling | en_US |
| dc.subject | Syndrome coronavirus 2 | en_US |
| dc.subject | Multiple Sequence Alignment | en_US |
| dc.subject | Deletion | en_US |
| dc.title | Analysis of Three Mutations in Italian Strains of Sars-Cov Implications for Pathogenesis | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Demir, Ayse Banu/0000-0003-4616-8151 | |
| gdc.author.id | Ciccozzi, Massimo/0000-0003-3866-9239 | |
| gdc.author.id | Benvenuto, Domenico/0000-0003-3833-2927 | |
| gdc.author.scopusid | 57208408457 | |
| gdc.author.scopusid | 57196655662 | |
| gdc.author.scopusid | 37008965500 | |
| gdc.author.scopusid | 8791594200 | |
| gdc.author.scopusid | 6701834393 | |
| gdc.author.wosid | Demir, Ayse Banu/E-1142-2017 | |
| gdc.author.wosid | Ciccozzi, Massimo/AAC-3271-2022 | |
| gdc.author.wosid | Benedetti, Francesca/AAE-7229-2022 | |
| gdc.author.wosid | Benvenuto, Domenico/AAO-5576-2020 | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Benvenuto, Domenico; Ciccozzi, Massimo] Campus Biomed Univ, Med Stat & Mol Epidemiol Unit, Via Alvaro Portillo 21, IT-00128 Rome, Italy; [Benedetti, Francesca; Zella, Davide] Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St N458, Baltimore, MD 21201 USA; [Benedetti, Francesca; Zella, Davide] Univ Maryland, Sch Med, Global Virus Network Ctr, Dept Biochem & Mol Biol, 725 W Lombard St N458, Baltimore, MD 21201 USA; [Demir, Ayse Banu] Izmir Univ Econ, Sch Med, Dept Med Biol, Izmir, Turkey | en_US |
| gdc.description.endpage | 37 | en_US |
| gdc.description.issue | 1.Şub | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q3 | |
| gdc.description.startpage | 33 | en_US |
| gdc.description.volume | 66 | en_US |
| gdc.description.wosquality | Q3 | |
| gdc.identifier.openalex | W3137526831 | |
| gdc.identifier.pmid | 33735872 | |
| gdc.identifier.wos | WOS:000632552400001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | BRONZE | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 5.0 | |
| gdc.oaire.influence | 2.815361E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | Italy | |
| gdc.oaire.keywords | Whole Genome Sequencing | |
| gdc.oaire.keywords | SARS-CoV-2 | |
| gdc.oaire.keywords | Epidemiological Monitoring | |
| gdc.oaire.keywords | Mutation | |
| gdc.oaire.keywords | Spike Glycoprotein, Coronavirus | |
| gdc.oaire.keywords | COVID-19 | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.popularity | 5.4390905E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.3217 | |
| gdc.openalex.normalizedpercentile | 0.59 | |
| gdc.opencitations.count | 5 | |
| gdc.plumx.crossrefcites | 5 | |
| gdc.plumx.mendeley | 37 | |
| gdc.plumx.pubmedcites | 4 | |
| gdc.plumx.scopuscites | 5 | |
| gdc.scopus.citedcount | 5 | |
| gdc.virtual.author | Demir, Ayşe Banu | |
| gdc.wos.citedcount | 4 | |
| relation.isAuthorOfPublication | ecd1c9da-04b3-4522-813f-ee86b06b7d1b | |
| relation.isAuthorOfPublication.latestForDiscovery | ecd1c9da-04b3-4522-813f-ee86b06b7d1b | |
| relation.isOrgUnitOfPublication | 4cbb0a74-ee1a-438b-b714-b8ef253df94b | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 4cbb0a74-ee1a-438b-b714-b8ef253df94b |
Files
Original bundle
1 - 1 of 1
